Editorial comment. Sex hormones and the risk of incident prostate cancer

Editorial

Jean-Alfred Thomas 2nd et al. Urology. 2010 Nov.

. 2010 Nov;76(5):1040-1.

doi: 10.1016/j.urology.2010.02.040.

No abstract available

Comment on

Sex hormones and the risk of incident prostate cancer.
Daniels NA, Nielson CM, Hoffman AR, Bauer DC; Osteoporotic Fractures In Men (MrOS) Study Group. Daniels NA, et al. Urology. 2010 Nov;76(5):1034-40. doi: 10.1016/j.urology.2010.01.086. Epub 2010 May 7. Urology. 2010. PMID: 20451981 Free PMC article.

Prediagnostic serum hormones and the risk of prostate cancer.
Nomura A, Heilbrun LK, Stemmermann GN, Judd HL. Nomura A, et al. Cancer Res. 1988 Jun 15;48(12):3515-7. Cancer Res. 1988. PMID: 3370644
Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer.
Carpenter WR, Robinson WR, Godley PA. Carpenter WR, et al. J Natl Cancer Inst. 2008 Feb 6;100(3):158-9. doi: 10.1093/jnci/djm329. Epub 2008 Jan 29. J Natl Cancer Inst. 2008. PMID: 18230791 No abstract available.
Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E. Platz EA, et al. Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1262-9. doi: 10.1158/1055-9965.EPI-04-0371. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15894683
Androgenic hormones and prostate cancer risk: status and prospects.
Gann PH. Gann PH. IARC Sci Publ. 2002;156:283-8. IARC Sci Publ. 2002. PMID: 12484188 Review. No abstract available.
The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
Platz EA, Giovannucci E. Platz EA, et al. J Steroid Biochem Mol Biol. 2004 Nov;92(4):237-53. doi: 10.1016/j.jsbmb.2004.10.002. Epub 2005 Jan 5. J Steroid Biochem Mol Biol. 2004. PMID: 15663987 Review.